Tag Archives: Blue Cross

Highmark’s Strategy to Contain Drug Costs Includes an Increasing Number of Outcome-Based Contracts

Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years

Programs Covering the Cost of Gene Therapies Increase

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Florida Blue’s Truli for Health HMO Targeted to Small and Mid-Sized Employers

Truli for Health will expand health care coverage options for local businesses through partnerships with community healthcare providers

Market Access Programs for Gene Therapies Increasing

Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs

Highmark Develops Initiatives to Control Drug Spending

Highmark members will receive hemophilia drugs exclusively from three specialty pharmacies